New Adamantane Phenylalkylamines with σ-Receptor Binding Affinity and Anticancer Activity, Associated with Putative Antagonism of Neuropathic Pain-Reference-Cited by-同舟云学术

New Adamantane Phenylalkylamines with σ-Receptor Binding Affinity and Anticancer Activity, Associated with Putative Antagonism of Neuropathic Pain

Published:2012-11-09 Issue:22 Volume:55 Page:10241-10261
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Riganas Stefanos¹²,Papanastasiou Ioannis¹,Foscolos George B.¹,Tsotinis Andrew¹,Serin Guillaume³,Mirjolet Jean-François³,Dimas Kostas⁴,Kourafalos Vassilios N.²,Eleutheriades Andreas²,Moutsos Vassilios I.²,Khan Humaira²,Georgakopoulou Stavroula²,Zaniou Angeliki²,Prassa Margarita²,Theodoropoulou Maria²,Mantelas Athanasios²,Pondiki Stavroula²,Vamvakides Alexandre²

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimioupoli-Zografou, 15771 Athens, Greece

2. Anavex Life Sciences, 27 Marathonos Avenue, 15351 Pallini, Athens, Greece

3. Oncodesign S.A., 20 Rue Mazen, F-21076 Dijon, France

4. Division of Pharmacology, Foundation for Biomedical Research of the Academy of Athens (FBRAA), 11527 Athens, Greece

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm3013008

Reference68 articles.

1. Sigma receptors and their ligands in cancer biology: overview and new perspectives for cancer therapy

2. The pharmacology of sigma-1 receptors